MRI引导下经会阴前列腺穿刺活检前无需抗生素预防
结果显示穿刺后感染发生率为0.9%(18例),仅0.2%(4例)需住院静脉抗生素治疗,非感染性并发症发生率为1.0%(19例)。结论认为无抗生素预防下TPBx后感染罕见,即使存在糖尿病或留置导尿管等传统风险因素也可安全省略抗生素预防。
要点
- 无抗生素预防的经会阴前列腺穿刺活检后感染率低于1.0%。
- 仅0.2%患者需住院静脉抗生素治疗,无重症监护入住。
- 糖尿病或留置导尿管患者感染风险未见显著增加。
核心结论
- 无抗生素预防下经会阴前列腺穿刺活检后感染罕见,发生率低于1.0%,可安全省略抗生素预防。
主要发现
- 18例(0.9%)发生穿刺后感染,其中4例(0.2%)需住院静脉抗生素治疗,无重症监护入住,14例(0.7%)门诊口服抗生素治疗。
- 非感染性并发症见于19例(1.0%)。
- 年龄、PSA水平、前列腺体积、PSA密度、穿刺针数、糖尿病、留置导尿管及免疫抑制剂使用与穿刺后感染均无显著关联。
关键数值与推荐
- 穿刺后感染定义为活检后2周内因尿路感染开具抗生素处方或30天内因感染住院治疗。
- 非感染性并发症定义为活检后2周内发生的任何非感染性并发症。
临床怎么用
- 对于接受经会阴前列腺穿刺活检以检测前列腺癌的患者,可考虑安全省略抗生素预防,即使存在糖尿病或留置导尿管等传统风险因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate rates of infectious and non-infectious complications after transperineal prostate biopsy (TPBx) without antibiotic prophylaxis (ABP) and to identify potential risk factors for post-biopsy infections. METHODS: We conducted an observational cohort study among patients who underwent TPBx without ABP at two high-volume diagnostic prostate cancer centers in an outpatient setting between February 2020 and October 2023. The primary outcome was post-TPBx infection, defined as an antibiotic prescription for urinary tract infection within 2 weeks post-biopsy or inpatient care for infection within 30 days. The secondary outcome was any non-infectious complication within 2 weeks after biopsy. We analyzed the following factors in relation to post-TPBx infection: age, prostate-specific antigen (PSA) level, prostate volume, PSA density, number of biopsy cores, diabetes mellitus, an indwelling catheter, and immunosuppressant use. RESULTS: A total of 1966 TPBx procedures in 1814 patients were included. Eighteen patients (0.9%) developed a post-biopsy infection; four (0.2%) required hospital admission and were treated with intravenous antibiotics. None of them required admission to the intensive care unit. The remaining 14 patients (0.7%) were treated in an outpatient setting and received oral antibiotics. We found no significant risk factors associated with infections. Non-infectious complications were observed in 19 patients (1.0%). CONCLUSION: Post-TPBx infections without ABP were rare, occurring in less than 1.0% of cases, even among patients with diabetes or an indwelling catheter. Our results suggest that ABP may be safely omitted in patients undergoing TPBx for prostate cancer detection, even in patients with traditional risk factors.
引用
- Westerhout SF, Rynja SP, van Steenbergen JPZ, et al. Antibiotic Prophylaxis Is Not Required Before MRI-Guided Transperineal Prostate Biopsy. Urology. 2025. PMID: 40783129. doi:10.1016/j.urology.2025.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。